Coronary artery disease and ventricular tachyarrhythmia: pathophysiology and treatment
1Department of Cardiology, University of Ioannina, Greece. thkolet@cc.uoi.gr
Insights
Ventricular tachyarrhythmias, a common issue in coronary artery disease, are complex. This review covers their causes, treatments, and the effectiveness of implantable cardioverter-defibrillators (ICDs).
Area of Science:
- Cardiology
- Electrophysiology
- Medical Research
Background:
- Ventricular tachyarrhythmias frequently complicate coronary artery disease.
- Ischemia and genetic factors contribute to arrhythmias during acute myocardial infarction (MI), but mechanisms remain unclear.
- Primary percutaneous coronary interventions (PCIs) reduce arrhythmia incidence post-MI.
Purpose of the Study:
- To review current understanding of ventricular tachyarrhythmia pathophysiology.
- To explore treatment strategies across different clinical stages of coronary artery disease.
- To discuss the efficacy and limitations of current therapeutic approaches.
Main Methods:
- Literature review of pathophysiology and treatment of ventricular tachyarrhythmias.
- Analysis of prehospital, acute, and chronic phases of myocardial infarction.
- Evaluation of interventions including PCIs, antiarrhythmic drugs, and implantable cardioverter-defibrillators (ICDs).
Main Results:
- Antiarrhythmic drugs have limited value in the chronic phase.
- Implantable cardioverter-defibrillators (ICDs) are effective for terminating arrhythmias.
- Risk stratification for ICD candidates requires improvement.
Conclusions:
- Understanding ventricular tachyarrhythmia mechanisms in acute MI is crucial.
- Further research into reperfusion injury treatments is needed.
- Improved risk stratification is essential for optimizing ICD therapy in coronary artery disease patients.
Abstract:
Ventricular tachyarrhythmias are common consequences of coronary artery disease. During the prehospital phase of acute myocardial infarction (MI), ischemia-induced electrophysiological changes and genetic factors are responsible for their occurrence, but the precise pathophysiologic mechanisms are ill-understood. Primary percutaneous coronary interventions (PCIs) have decreased the incidence of ventricular tachyarrhythmias during subsequent stages, and future treatments ameliorating reperfusion injury may provide further progress. In the chronic phase, antiarrhythmic drug therapy targeted toward arrhythmogenic substrate has relatively limited value, but alternative approaches are still uncertain. By contrast, prompt arrhythmia termination by implantable cardioverter-defibrillators (ICDs) is highly effective, although risk-stratification algorithms in candidate patients are inadequate. This review explores current views in the pathophysiology and treatment of ventricular tachyarrhythmias at different clinical stages.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Mechanism of Cardiac Arrhythmias
Coronary Artery Disease II: Pathophysiology


